ANI Pharmaceuticals, Inc.

BST:BSFA Stock Report

Market Cap: €1.1b

ANI Pharmaceuticals Future Growth

Future criteria checks 4/6

ANI Pharmaceuticals is forecast to grow earnings and revenue by 57% and 9.1% per annum respectively while EPS is expected to grow by 54.2% per annum.

Key information

57.0%

Earnings growth rate

54.2%

EPS growth rate

Pharmaceuticals earnings growth21.3%
Revenue growth rate9.1%
Future return on equityn/a
Analyst coverage

Low

Last updated11 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BST:BSFA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026763681481984
12/31/202571835951475
12/31/2024599-342975
9/30/2024555-97493N/A
6/30/20245392494113N/A
3/31/20245173195116N/A
12/31/202348715100119N/A
9/30/2023449105370N/A
6/30/2023401-81941N/A
3/31/2023359-28-79N/A
12/31/2022316-50-48-31N/A
9/30/2022283-69-53-39N/A
6/30/2022251-65-52-48N/A
3/31/2022226-63-61-36N/A
12/31/2021216-43-203N/A
9/30/2021212-22-1610N/A
6/30/2021213-17-1714N/A
3/31/2021213-152334N/A
12/31/2020208-23-5315N/A
9/30/2020199-24-4226N/A
6/30/2020198-20-1549N/A
3/31/2020203-1-3233N/A
12/31/201920761846N/A
9/30/2019216164168N/A
6/30/2019215172855N/A
3/31/2019208143058N/A
12/31/2018202155667N/A
9/30/20181920-456N/A
6/30/20181890N/A64N/A
3/31/20181870N/A56N/A
12/31/2017177-1N/A39N/A
9/30/20171687N/A36N/A
6/30/20171585N/A20N/A
3/31/20171454N/A23N/A
12/31/20161294N/A27N/A
9/30/20161088N/A20N/A
6/30/20169010N/A29N/A
3/31/20167812N/A27N/A
12/31/20157615N/A17N/A
9/30/20157933N/A23N/A
6/30/20157735N/A17N/A
3/31/20156430N/A18N/A
12/31/20145629N/A22N/A
9/30/20144511N/A8N/A
6/30/2014365N/A3N/A
3/31/2014351N/A0N/A
12/31/201330-5N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BSFA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: BSFA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BSFA is expected to become profitable in the next 3 years.

Revenue vs Market: BSFA's revenue (9.1% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: BSFA's revenue (9.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if BSFA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y